Healthequity (HQY) Short term Debt (2019 - 2023)

Healthequity's Short term Debt history runs 5 years deep, the most recent figure standing at $17.5 million for Q1 2023.

• On a quarterly basis, Short term Debt rose 100.0% year-over-year to $17.5 million in Q1 2023; TTM through Jan 2023 was $17.5 million, a 100.0% increase from a year earlier, with the FY2023 full-year figure at $17.5 million, up 100.0% from the prior year.
• Short term Debt advanced to $17.5 million in Q1 2023 per HQY's latest filing, from $15.3 million in the prior quarter.
• Across five years, Short term Debt topped out at $78.1 million in Q3 2021 and bottomed at $6.6 million in Q4 2021.
• The 5-year median for Short term Debt is $35.2 million (2019), against an average of $36.4 million.
• Across the five-year window, Short term Debt sank 89.5% in 2021 and jumped 133.32% in 2022, its largest moves.
• Year by year, Short term Debt stood at $31.2 million in 2019, then soared by 100.0% to $62.5 million in 2020, then sank by 89.5% to $6.6 million in 2021, then soared by 133.32% to $15.3 million in 2022, then grew by 14.28% to $17.5 million in 2023.
• Per Business Quant, the three latest HQY Short term Debt figures stand at $17.5 million (Q1 2023), $15.3 million (Q4 2022), and $13.1 million (Q3 2022).